全文获取类型
收费全文 | 211366篇 |
免费 | 34066篇 |
国内免费 | 2583篇 |
专业分类
耳鼻咽喉 | 5971篇 |
儿科学 | 9589篇 |
妇产科学 | 3607篇 |
基础医学 | 10325篇 |
口腔科学 | 2986篇 |
临床医学 | 30541篇 |
内科学 | 58094篇 |
皮肤病学 | 9254篇 |
神经病学 | 17902篇 |
特种医学 | 8272篇 |
外科学 | 49978篇 |
综合类 | 2311篇 |
现状与发展 | 72篇 |
一般理论 | 27篇 |
预防医学 | 10073篇 |
眼科学 | 5979篇 |
药学 | 6730篇 |
1篇 | |
中国医学 | 464篇 |
肿瘤学 | 15839篇 |
出版年
2024年 | 708篇 |
2023年 | 5154篇 |
2022年 | 2446篇 |
2021年 | 5274篇 |
2020年 | 7154篇 |
2019年 | 3529篇 |
2018年 | 9242篇 |
2017年 | 8600篇 |
2016年 | 10168篇 |
2015年 | 10140篇 |
2014年 | 18049篇 |
2013年 | 18595篇 |
2012年 | 9799篇 |
2011年 | 9781篇 |
2010年 | 12796篇 |
2009年 | 16130篇 |
2008年 | 8752篇 |
2007年 | 7091篇 |
2006年 | 9195篇 |
2005年 | 6237篇 |
2004年 | 5322篇 |
2003年 | 4026篇 |
2002年 | 3843篇 |
2001年 | 5197篇 |
2000年 | 4294篇 |
1999年 | 4326篇 |
1998年 | 4115篇 |
1997年 | 3816篇 |
1996年 | 3684篇 |
1995年 | 3508篇 |
1994年 | 2183篇 |
1993年 | 1802篇 |
1992年 | 2046篇 |
1991年 | 2099篇 |
1990年 | 1733篇 |
1989年 | 1835篇 |
1988年 | 1579篇 |
1987年 | 1357篇 |
1986年 | 1372篇 |
1985年 | 1206篇 |
1984年 | 925篇 |
1983年 | 811篇 |
1982年 | 687篇 |
1981年 | 570篇 |
1980年 | 525篇 |
1979年 | 648篇 |
1978年 | 553篇 |
1977年 | 626篇 |
1975年 | 494篇 |
1972年 | 486篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
Surender Kumar Yachha Rakesh Aggarwal S Srinivas Anshu Srivastava Sanjay K Somani Srivenu Itha 《Indian journal of gastroenterology》2006,25(3):132-135
BACKGROUND: We prospectively evaluated the usefulness of IgA tissue transglutaminase antibodies (IgA tTG) in the initial diagnosis of celiac disease (CD) and compared its diagnostic potential with that of IgA anti-endomysial antibodies (IgA EMA) and anti-IgA and IgG gliadin antibodies (AGA and AGG, respectively). METHODS: Sera of 23 untreated children fulfilling the revised ESPGHAN criteria for diagnosis of CD (Group I; mean age 10.8 y); 19 disease controls (Group II; mean age 8.5 y) presenting with chronic diarrhea, short stature or both; and 22 healthy children (Group III; mean age 8.8 y) were studied. These were tested in a blinded manner for AGA, AGG, IgA tTG (guinea pig as antigen) and IgA EMA. RESULTS: In Group I, IgA EMA was positive in 19, IgA tTG in 17, AGA in 14 and AGG in 17 patients. In Group II, these tests were positive in 1, 0, 2 and 14 patients, respectively and in Group III, in 0, 0, 0 and 1 child, respectively. Analyzing data from Group I and II, IgA EMA, IgA tTG, AGA and AGG had sensitivity rates of 83%, 74%, 61% and 74%, respectively; the specificity rates were 95%, 100%, 89% and 26%; positive predictive values were 95%, 100%, 88% and 55% and negative predictive values were 82%, 74%, 65% and 45%, respectively. CONCLUSION: IgA tTG is useful for the diagnosis of CD, with sensitivity and specificity rates comparable to those of EMA and this test is well suited for use in tropical countries like India. 相似文献
44.
45.
46.
Prostatitis and male infertility are frequent disorders, and the role of prostatitis in male infertility has been under discussion for more than 30 years. Many researchers have shown relevant links between the two. Although a causal relationship has not been definitely demonstrated, increasing evidence shows that chronic prostatitis has a relevant negative impact on male fertility potential, at least in certain subgroups. In the following review, we focus on the present state of knowledge on the role of chronic prostatitis as an etiologic factor in male infertility. 相似文献
47.
J. Curtis Nickel MD 《Current Prostate Reports》2006,4(3):132-137
Medical therapy is currently the most popular treatment choice for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Because medical therapy of BPH-related LUTS is considered a life-long strategy, short- and long-term cost considerations should play a major role in therapeutic decision-making. The effectiveness in terms of long and short amelioration of symptoms, flow rate, and quality of life are well documented for 5α-blockers and 5α-reductase inhibitors as well as for the gold standard treatment for BPH, transurethral resection of the prostate and minimally invasive therapies. Short-and long-term safety concerns also are well documented for these various treatment options. On the contrary, short- and long-term costs have been less well studied and comparisons depend on the model or analyses undertaken in the few studies available. However, the economic studies based on prospective clinical trial data that have become available throughout the past several decades allow us to rationalize our use of α-blockers, 5α -reductase inhibitors, and combination therapy, taking into consideration age, severity of symptoms, prostate volume, prostate-specific antigen, and the differential response of the various medications (and combination) in selected patients. Based on current studies, 5α -blockers generally provide cost-effective therapy for most patients, whereas 5α-reductase therapy and combination therapy provide cost-effective treatment for patients with larger prostate glands or higher baseline prostate-specific antigen levels. 相似文献
48.
49.
50.
INTRODUCTION: The clinical presentation of morphea varies from localized plaques to generalized eruptions. Its cause remains unknown and medical treatments have often proved unsatisfactory. Studies have previously shown that improvement of hypertrophic scars and fibrotic skin can be achieved with the use of a 585 nm pulsed dye laser (PDL). METHODS: A case of plaque-type morphea was treated with 585 nm pulsed dye laser irradiation at an average fluence of 5.0 J/cm2 at bimonthly time intervals. RESULTS: Marked clinical improvement as evidenced by improved pliability and skin coloration was seen after 4 successive PDL treatments. No side effects or complications were encountered. CONCLUSION: Pulsed dye laser therapy is a viable treatment option for morphea. The mechanism of its effect in this condition remains unknown. 相似文献